TELA Bio lost its finance chief and 41 of its 201 staff on the same document, and the chief executive has taken the principal financial officer role herself

Roberto Cuca ran finance and operations at TELA Bio for five years. On Monday morning he stepped down from both jobs, along with the corporate secretary role and the principal financial officer designation, and the board handed that last title to Heather Getz, who is already the chief executive.

The same filing says the company is cutting 41 of its 201 full-time employees.

The plan

The board approved it on Friday. The workforce goes from 201 to 160, a reduction of about 20 percent, and the company expects it to be substantially complete during the third quarter. Charges are put at about $1.5m, primarily severance and other employee-related costs, substantially all of it cash, all of it landing in the same quarter.

The company says the point is to reduce operating expenses and preserve capital in order to focus on improving product sales.

What it saves

The press release attached to the filing carries the number the 8-K does not. Annual operating expenses come down by about $17.0m, which the company puts at 18 percent. Taken together those two figures imply an operating expense base of roughly $94m, though the percentage is rounded and the implied base with it.

Headcount is not the whole of it, and the company says so. The saving is described as driven by the 20 percent reduction and by the streamlining of external resources, which matters, because $17.0m spread across 41 posts alone would be about $415,000 each.

The ratio worth keeping is the other one. A one-time charge of $1.5m buys $17.0m a year, about eleven to one, and TELA Bio says the effect is to extend its cash runway into 2028.

What the filing does not say

There is no cash balance in it, and no revenue figure, so the runway claim arrives without anything in the same document to measure it against. Nor are the terms of Mr Cuca's separation stated. His departure is treated as a termination without cause under his existing employment agreement, and the separation agreement is promised as an exhibit to the third quarter accounts.

The company says it will say more on its third quarter earnings call, planned for early November.